Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Elbasvir–grazoprevir

Brand: Zepatier ®
NICE TA: 413
Indication: Chronic Hepatitis C (NICE TA413)
Disease category: Infections
Commissioning responsibility: NHS England
PbR excluded: Yes

Background

Elbasvir–grazoprevir is recommended, within its marketing authorisation, as an option for treating genotype 1 or 4 chronic hepatitis C in adults only if the company provides the drug at the same price or lower than that agreed with the Commercial Medicines Unit.
It is recommended that the decision to treat and prescribing decisions are made by multidisciplinary teams in the operational delivery networks put in place by NHS England, to prioritise treatment for people with the highest unmet clinical need.

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

NICE TA413 - Elbasvir–grazoprevir for treating chronic hepatitis C

 

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red